We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Ketogenic Diet for Reduction of CNS Oxygen Toxicity in Working Divers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03433261
Recruitment Status : Completed
First Posted : February 14, 2018
Last Update Posted : December 14, 2021
United States Department of Defense
Information provided by (Responsible Party):
Duke University

Brief Summary:
The purpose of this research study is to understand the effect of nutritional ketosis on CNS oxygen toxicity in undersea divers. The investigators hope this will provide a starting point to develop methods for improving the safety of Navy divers, warfighters and submariners.

Condition or disease Intervention/treatment Phase
CNS Oxygen Toxicity, Ketogenic Diet Dietary Supplement: Ketogenic Diet Not Applicable

Detailed Description:
Participants in the study will undergo a physical exam and testing as well as training on cognitive testing software as part of the screening process. Eligible subjects will be assigned a normal diet or a ketogenic diet (a diet high in fat/protein and low in carbohydrates) for three days before testing. Subjects will be immersed in water to the shoulders, inside a hyperbaric (high pressure) chamber while breathing 100% oxygen at increased atmospheric pressure, and doing cycling exercise. Testing on the cognitive software, as well as blood sampling and physical monitoring will be done while in the chamber. All tests and procedures will be completed again at least one week later with the diet not assigned for the first session.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 91 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Intervention Model Description: Each subject will randomize to one of two arms and will crossover to the other arm at least one week later.
Masking: Double (Investigator, Outcomes Assessor)
Masking Description: Neither the investigator nor the outcomes assessor will no the ketone level of the participant during either arm of the study
Primary Purpose: Prevention
Official Title: Ketogenic Diet for Reduction of Oxygen Toxicity in Working Divers
Actual Study Start Date : March 1, 2018
Actual Primary Completion Date : October 30, 2021
Actual Study Completion Date : October 30, 2021

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Oxygen Therapy

Arm Intervention/treatment
No Intervention: Normal Diet
The participant will eat their usual diet for at least 72 hrs prior to the experiment, document their diet during that time and be tested for ketone level immediately prior to the experiment.
Experimental: Ketogenic Diet
The participant will follow a ketogenic diet for 72 hrs prior to the experiment and consume a ketone supplement 60 minutes prior to the experiment. They will document their diet and be tested for ketone level immediately prior to the experiment.
Dietary Supplement: Ketogenic Diet
Eat a ketogenic diet (low carbohydrate, high fat diet) for 72 hrs prior to the experiment and consume a dietary ketone supplement 60 minutes before the experiment.

Primary Outcome Measures :
  1. Time to First Manifestations of CNS Oxygen Toxicity [ Time Frame: 2 hrs ]
    Time to the first manifestation of CNS Oxygen Toxicity: visual or hearing changes, nausea, twitching, irritability, dizziness, convulsions or change consistent with possible CNS Oxygen Toxicity.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 50 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Males & females between 18 and 50 years old
  • Able to pedal a bicycle ergometer continuously for 15 minutes
  • Non-smoker
  • No history of cardiovascular disease, including coronary artery disease, valvular disease, cardiomyopathy or hypertension.
  • No history of lung disease

Exclusion Criteria:

  • Prolonged QTc on initial ECG
  • Currently pregnant or attempting to become pregnant.
  • Have a history of:

    1. Smoking
    2. Coronary artery disease
    3. Hypertension
    4. Seizures
    5. Exercise intolerance
    6. Psychiatric disorder
    7. Previous pneumothorax or pneumomediastinum
    8. Hypo or hyperglycemia
    9. Diabetes
  • Regularly take any medications which may alter heart rate, blood pressure, neurotransmitter function, mood or affect.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03433261

Layout table for location information
United States, North Carolina
Duke University Hospital
Durham, North Carolina, United States, 27710
Sponsors and Collaborators
Duke University
United States Department of Defense
Layout table for additonal information
Responsible Party: Duke University
ClinicalTrials.gov Identifier: NCT03433261    
Other Study ID Numbers: Pro00070499
First Posted: February 14, 2018    Key Record Dates
Last Update Posted: December 14, 2021
Last Verified: November 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Signs and Symptoms, Respiratory